Amphastar Pharmaceuticals, Inc.
AMPH· Nasdaq
AMPHAmphastar Pharmaceuticals, Inc.
Filed Nov 13, 2014 · 10-Q · 44 days after period end · 0001171843-14-005537
| Metric | Q3 2014 | Q3 2013 |
|---|---|---|
| Revenue | $59.71M | $59.32M |
| Net Income | -$5.38M | -$160.00K |
| EPS Diluted | -$0.12 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Amphastar Pharmaceuticals, Inc. · CIK 1297184 · Engraved from SEC EDGAR
ended Sep 30, 2014 · filed Nov 13, 2014 · 44 d after period end
